Flu trial success menas NAL's immunology holding is worth over 50 cents a share.
Yesterday's announcmeent shows flu vaccine progressing to Phase II
Flu trial success menas NAL's immunology holding is worth over...
Add to My Watchlist
What is My Watchlist?